We are very pleased to be attending the Infectious Diseases Virtual Partnering from 2-4 December, 2020. If you have any questions, please contact our specialist.

Vector B2B – Drug Development will present our new services available to all pharmaceutical & biotechnology companies developing new treatments for many infectious diseases for which there are not satisfactory preventive tools or treatment options.